TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation
Hyun-Kyoung Kim,Kashi Raj Bhattarai,Raghu Patil Junjappa,Jin Hee Ahn,Suvarna H. Pagire,Hyun Ju Yoo,Jaeseok Han,Duckgue Lee,Kyung-Woon Kim,Hyung-Ryong Kim,Han-Jung Chae +10 more
Reads0
Chats0
TLDR
It is shown that TMBIM6 regulates AKT activation through mTORC2 assembly and ribosome association and an antagonist of TMBIm6 with anti-tumor properties is identified.Abstract:
Transmembrane B cell lymphoma 2-associated X protein inhibitor motif-containing (TMBIM) 6, a Ca2+ channel-like protein, is highly up-regulated in several cancer types. Here, we show that TMBIM6 is closely associated with survival in patients with cervical, breast, lung, and prostate cancer. TMBIM6 deletion or knockdown suppresses primary tumor growth. Further, mTORC2 activation is up-regulated by TMBIM6 and stimulates glycolysis, protein synthesis, and the expression of lipid synthesis genes and glycosylated proteins. Moreover, ER-leaky Ca2+ from TMBIM6, a unique characteristic, is shown to affect mTORC2 assembly and its association with ribosomes. In addition, we identify that the BIA compound, a potentialTMBIM6 antagonist, prevents TMBIM6 binding to mTORC2, decreases mTORC2 activity, and also regulates TMBIM6-leaky Ca2+, further suppressing tumor formation and progression in cancer xenograft models. This previously unknown signaling cascade in which mTORC2 activity is enhanced via the interaction with TMBIM6 provides potential therapeutic targets for various malignancies. TMBIM6, a member of the transmembrane BI-1 motif-containing family of proteins, is overexpressed in many cancer types. Here, the authors show that TMBIM6 regulates AKT activation through mTORC2 assembly and ribosome association and identify an antagonist of TMBIM6 with anti-tumor properties.read more
Citations
More filters
Journal ArticleDOI
A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer
TL;DR: Wang et al. as discussed by the authors developed a novel glycolysis-associated multifactor prediction model for better predicting the prognosis of Prostate cancer (PCa) using differentially mRNA expression profiles derived from the Cancer Genome Atlas (TCGA) PCa cohort.
Journal ArticleDOI
Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.
Yujia Wang,Lushuang Xu,Yang Liu,Yuzhe Hu,Qiang Shi,Lixue Jin,Lijun Yang,Pingzhang Wang,Kunshan Zhang,Xiao-Jun Huang,Qing Ge,Jin Lu,Jin Lu +12 more
TL;DR: It is demonstrated that aberrant PCs in AL has a highly diverse transcriptome, an upregulation of MHC, and a dampened capability of immunosurveillance by reduction of circulating NK frequencies.
Journal ArticleDOI
Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy
Wei-wei Pei,Ling Cai,Xing Gong,Li Zhang,Jiarong Zhang,Ping Zhu,Huijun Jiang,Chao-ran Wang,ShouLin Wang Zhan Zhang Shushu Li Li Wang Xichen Wang,Jin Chen +9 more
TL;DR: In this article , the mesoregular structure and peculiar tumoricidal effect of BAMLET provided a manipulable nanoplatform as drug nanocarrier for therapeutic applications, and in vivo study showed that MSN-BAMLET/DTX contributed to the effective cancer ablation and the prolonged survival.
Journal ArticleDOI
Morin Acts as a USP7 Inhibitor to Hold Back the Migration of Rheumatoid Arthritis Fibroblast-Like Synoviocytes in a "Prickle1-mTORC2" Dependent Manner.
TL;DR: In this paper, the effect and detailed mechanisms of morin, an anti-arthritis compound widely distributed in foods of plant origin, on the pathological migration of fibroblast-like synoviocytes (FLS) were investigated.
Posted ContentDOI
Newfound coding potential of transcripts unveils missing members of human protein communities
Sebastien Leblanc,Marie A. Brunet,Jean-François Jacques,Amina M. Lekehal,Andréa Duclos,Alexia Tremblay,Alexis Bruggeman-Gascon,Sondos Samandi,Mylène Brunelle,Alan A. Cohen,Michelle S. Scott,Xavier Roucou +11 more
TL;DR: This work uses the proteogenomic resource OpenProt and a combined spectrum- and peptide-centric analysis for the re-analysis of a high throughput human network proteomics dataset thereby revealing the presence of 280 alternative proteins in the network and suggesting functional roles for hundreds of alternative proteins.
References
More filters
mTOR Signaling in Growth Control and Disease
TL;DR: The mechanistic target of rapamycin (mTOR) signaling pathway senses and integrates a variety of environmental cues to regulate organismal growth and homeostasis as mentioned in this paper, and is implicated in an increasing number of pathological conditions, including cancer, obesity, type 2 diabetes, and neurodegeneration.
Journal ArticleDOI
mTOR signaling in growth control and disease.
TL;DR: Recent advances in understanding of the mTOR pathway are reviewed and pharmacological approaches to treat human pathologies linked to mTOR deregulation are discussed.
PatentDOI
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
TL;DR: In this paper, the rictor-mTOR complex was used to identify compounds which modulate Akt activity mediated by the Rictor mTOR complex and methods for treating or preventing a disorder that is associated with aberrant Akt activation.
Journal ArticleDOI
mTOR Signaling in Growth, Metabolism, and Disease.
TL;DR: Recent advances in understanding of mTOR function, regulation, and importance in mammalian physiology are reviewed and how the mTOR signaling network contributes to human disease is highlighted.
Journal ArticleDOI
mTOR: from growth signal integration to cancer, diabetes and ageing
TL;DR: Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt.